Cover Fx Invisible Primer Spf30 Lotion
NDC Package 68577-105-00
Package Information
Cover Fx Invisible Primer Spf30 (avobenzone, homosalate, octisalate, octocrylene) lotions is apply liberally 15 minutes before sun exposure.Apply to all skin exposed to the sun.Children under 6 months: Ask a doctor.Use a water-resistant sunscreen if swimming or sweating.Reapply at least every 2 hours.Sun Protection Measures: Spending time in the sun increases your risk of skin cancer and early skin aging.To decrease this risk, regularly use a sunscreen with a Broad Spectrum SPF value of 15 or higher and take other sun protection measures.Limit time in the sun, especially from 10 a.m.-2 p.m.Wear long-sleeved shirts, pants, hats and sunglasses. This formulation utilizes a lotion delivery system. Marketed by Cosmax Usa, Corporation, this product is identified by NDC 68577-105 and is authorized under FDA application M020.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 68577 - Cosmax Usa, Corporation
- 68577-105 - Cover Fx Invisible Primer Spf30
- 68577-105-00 - 1 TUBE in 1 CARTON / 30 mL in 1 TUBE
- 68577-105 - Cover Fx Invisible Primer Spf30
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 68577-105-00 identifies a specific commercial package of 1 tube in 1 carton / 30 ml in 1 tube of Cover Fx Invisible Primer Spf30, a human over the counter drug labeled by Cosmax Usa, Corporation. This lotion is formulated for topical use and contains avobenzone; homosalate; octisalate; octocrylene as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Cosmax Usa, Corporation on April 28, 2023. The current certification is valid through December 31, 2026.
How is this Cosmax Usa, Corporation product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 68577010500. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.